Immunohistochemical expression of GCET1 in major human lymphoma subtypes
| Diagnosis . | Cases studied, no. . | GCET1+, no. (%) . |
|---|---|---|
| B-cell lymphomas | ||
| Chronic lymphocytic leukemia/small lymphocytic lymphoma | 20 | 0 (0) |
| Splenic marginal zone lymphoma | 8 | 0 (0) |
| Mantle cell lymphoma, classic variant | 19 | 0 (0) |
| Burkitt lymphoma | 19 | 7 (37) |
| Follicular lymphoma | 89 | 82 (92) |
| Diffuse large B-cell lymphoma* | 72 | 34 (47) |
| T-cell /histiocyte-rich B-cell lymphoma | 13 | 7 (54) |
| Hodgkin lymphoma | ||
| Nodular lymphocyte predominant Hodgkin lymphoma | 40 | 38 (95) |
| Lymphocyte rich classical Hodgkin lymphoma | 15 | 2 (13) |
| Other classical Hodgkin lymphoma (mixed cellularity and nodular sclerosis) | 56 | 0 (0) |
| T-cell lymphoma, peripheral, not otherwise specified | 18 | 0 (0) |
| Diagnosis . | Cases studied, no. . | GCET1+, no. (%) . |
|---|---|---|
| B-cell lymphomas | ||
| Chronic lymphocytic leukemia/small lymphocytic lymphoma | 20 | 0 (0) |
| Splenic marginal zone lymphoma | 8 | 0 (0) |
| Mantle cell lymphoma, classic variant | 19 | 0 (0) |
| Burkitt lymphoma | 19 | 7 (37) |
| Follicular lymphoma | 89 | 82 (92) |
| Diffuse large B-cell lymphoma* | 72 | 34 (47) |
| T-cell /histiocyte-rich B-cell lymphoma | 13 | 7 (54) |
| Hodgkin lymphoma | ||
| Nodular lymphocyte predominant Hodgkin lymphoma | 40 | 38 (95) |
| Lymphocyte rich classical Hodgkin lymphoma | 15 | 2 (13) |
| Other classical Hodgkin lymphoma (mixed cellularity and nodular sclerosis) | 56 | 0 (0) |
| T-cell lymphoma, peripheral, not otherwise specified | 18 | 0 (0) |
GC: 21/31+; non-GC: 3/21+ (according to Hans et al19 ).